# Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers

> **NCT02604004** · PHASE1 · COMPLETED · sponsor: **Universidade Federal de Pernambuco** · enrollment: 28 (actual)

## Conditions studied

- HIV INFECTIONS

## Interventions

- **DRUG:** Epivir ® tablet 150-mg single dose (drug reference)
- **DRUG:** Lamivudine 150-mg tablet single dose (drug test)

## Key facts

- **NCT ID:** NCT02604004
- **Lead sponsor:** Universidade Federal de Pernambuco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02604004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02604004, "Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02604004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*